Equities

Teuza - A Fairchild Technology Venture Ltd.

TUZA:TLV

Teuza - A Fairchild Technology Venture Ltd.

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (ILa)36.50
  • Today's Change-2.10 / -5.44%
  • Shares traded180.00
  • 1 Year change-34.35%
  • Beta0.0227
Data delayed at least 20 minutes, as of May 12 2024 13:49 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Teuza A Fairchild Technology Venture Ltd is an Israel-based investment company active in the fields of software, communications, electronics, medical equipment and healthcare in all stages. All of the Company's investments are in equity or equity-linked securities, and take place in all stages of venture funding, from seed to start-up and through later stage growth. The Company's portfolio includes Nova Measuring Instruments Ltd, Bioness / N.E.S.S DTL, Sagantec, Qualion, ADT, ANTT, Monitel, Digiflex and Media Boost. The Company provides close support for its portfolio companies, by building an entry strategy into new markets and raising capital for expansion. It also provides its portfolio companies the business network that it has built in the international markets, including in the United States, Europe, China, and Japan.

  • Revenue in ILS (TTM)0.00
  • Net income in ILS-7.36m
  • Incorporated1991
  • Employees--
  • Location
    Teuza - A Fairchild Technology Venture Ltd.Hahistadrut 49HAIFA 31250IsraelISR
  • Phone+972 48728788
  • Fax+972 48729393
  • Websitehttps://www.teuzafund.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Unicorn Technologies LP0.00-13.87m15.33m----0.3258-----0.3963-0.39630.001.340.00-------25.20---25.73-------------0.34380.00-------106.29------
Merchavia Holdings and Investments Ltd460.00k-16.23m15.76m1.23k--0.5453--34.25-3.87-3.870.04091.720.0121--1.53374.59-42.78-3.37-43.98-3.46-----3,528.48-185.15---0.13460.00--90.08-10.25-349.99--37.97--
Technoplus Ventures Ltd765.74k130.10k18.62m3.00136.740.9794143.0824.310.0580.0580.32828.100.0363--10.30--0.6175-1.710.6395-1.78----16.99-23.59----0.0537--402.44-21.95102.56-15.24----
Teuza A Fairchild Technology Venture Ltd0.00-7.36m43.87m----0.6955-----0.0646-0.06460.000.55360.00-------10.70-6.14-11.06-6.65-----------1.690.00------69.78------
Eldav Investments Ltd13.15m-2.31m72.99m3.00--0.6274--5.55-0.1096-0.10960.3413.250.1066--12.104,384,000.00-1.881.91-1.912.62-----17.5911.20--0.61540.0012191.7848.43-38.1379.54---45.42--
Clal Biotechnology Industries Ltd.39.14m-31.05m81.87m3.00--0.824--2.09-0.1934-0.19340.28150.63350.2295--15.3813,047,000.00-16.47-13.69-19.34-23.73-----71.77-121.02---0.34370.0713--327.77-12.67-323.44---72.00--
Data as of May 12 2024. Currency figures normalised to Teuza - A Fairchild Technology Venture Ltd.'s reporting currency: Israeli Shekel ILS
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.